Preview

Nephrology (Saint-Petersburg)

Advanced search
Open Access Open Access  Restricted Access Subscription Access

Uromodulin as a kidney protective factor in acute oxalate urolithiasis: a dose-dependent mouse model

https://doi.org/10.36485/1561-6274-2026-30-2-96-110

EDN: JQBRTS

Abstract

INTRODUCTION . Urolithiasis is a common urological pathology with a high recurrence rate. Experimental models on rodents are the main tool for studying the pathogenesis of stone formation and the search for therapeutic targets.

THE AIM: To develop models of acute oxalate urolithiasis in ICR mice and evaluate the role of uromodulin (UMO) in protecting the kidneys from crystal-induced damage.

MATERIALS AND METHODS. The study was performed on 18 male ICR mice (CD 1). Mice were intraperitoneally injected with sodium oxalate in two doses: 2.5 mg/100 g body weight (NaOx L) and 5 mg/100 g body weight (NaOx H). The biochemical parameters of blood, glomerular filtration rate by FITC inulin clearance, colloidal composition of urine, urinary excretion of UMO and ions, morphology of sediment and internal organs were evaluated in the experiment.

RESULTS . A high dose of the pathology inducer caused severe acute nephropathy with pronounced azotemia, decreased GFR, accumulation of large CaOx containing nanoparticles, and deep tubulointerstitial damage. A dose of 2.5 mg/100 g of body weight formed a milder, generally compensated lesion with a transient peak of crystalluria. In this group, the dynamics of urinary UMO excretion and colloidal profile most convincingly demonstrated its nephroprotective and anti-crystallogenic role.

CONCLUSIONS. The developed two-dose model of acute Ox urolithiasis in mice allows differentiated study of severe crystal-induced kidney damage (5 mg/100 g) and mechanisms of effective crystal clearance with the participation of UMO (2.5 mg/100 g), which creates the basis for molecular genetic studies on transgenic and knockout lines of mice.

About the Authors

N. A. Verlov
Petersburg Nuclear Physics Institute named by B.P.Konstantinov of National Research Centre «Kurchatov Institute»
Russian Federation

Nikolay A. Verlov, PhD, Head of Resource Center of the Molecular and Radiation Biophysics Division

188300, Leningradskaya oblast, Gatchina 1, mkr. Orlova roshcha

 



V. S. Burdakov
Petersburg Nuclear Physics Institute named by B.P.Konstantinov of National Research Centre «Kurchatov Institute»
Russian Federation

Junior researcher Vladimir S. Burdakov, staff scientist of the Molecular and Radiation Biophysics Division

188300, Leningradskaya oblast, Gatchina 1, mkr. Orlova roshcha



T. A. Antysheva
Petersburg Nuclear Physics Institute named by B.P.Konstantinov of National Research Centre «Kurchatov Institute»
Russian Federation

Taisiya A. Antysheva

188300, Leningradskaya oblast, Gatchina 1, mkr. Orlova roshcha



L. A. Ivanova
Petersburg Nuclear Physics Institute named by B.P.Konstantinov of National Research Centre «Kurchatov Institute»
Russian Federation

Junior researcher Lyubov A. Ivanova, staff scientist of the Molecular and Radiation Biophysics Division

188300, Leningradskaya oblast, Gatchina 1, mkr. Orlova roshcha

 



D. V. Mukhametdinova
Petersburg Nuclear Physics Institute named by B.P.Konstantinov of National Research Centre «Kurchatov Institute»
Russian Federation

Senior laboratory assistant Darya V. Mukhametdinova

188300, Leningradskaya oblast, Gatchina 1, mkr. Orlova roshcha



S. B. Landa
Petersburg Nuclear Physics Institute named by B.P.Konstantinov of National Research Centre «Kurchatov Institute»
Russian Federation

Sergey B. Landa, PhD, senior researcher of the Molecular and Radiation Biophysics Division

188300,  Leningradskaya oblast, Gatchina 1, mkr. Orlova roshcha

 



K. Dyussupova
First Pavlov State Medical University of St. Petersburg
Russian Federation

Karina Dyussupova, Department of Clinical Laboratory Diagnostics with a course in Molecular Medicine, Research and Methodological Center of the Ministry of Health of the Russian Federation for Molecular Medicine, Laboratory of Autoimmune Disease Diagnostics

197022, Saint Petersburg, 6–8D Lev Tolstoy St., Bldg. 11

 



V. L. Emanuel
First Pavlov State Medical University of St. Petersburg
Russian Federation

Professor Vladimir L. Emanuel, MD, PhD, DMedSci, Department of Clinical Laboratory Diagnostics with a course in Molecular Medicine, Head of the Department

197022, Saint Petersburg, 6–8D Lev Tolstoy St., Bldg. 11

 



References

1. Bilbault H, Haymann JP. Experimental models of renal calcium stones in rodents. World J Nephrol 2016;5(2):189–194. doi:10.5527/wjn.v5.i2.189

2. de Araújo L, et al. Sodium oxalate-induced acute kidney injury associated with glomerular and tubulointerstitial damage in rats. Front Physiol 2020;11:107. doi:10.3389/fphys.2020.00107

3. Khan SR, Glenton PA. Of mice and men: experimental induction of calcium oxalate nephrolithiasis in mice. J Urol 2010;184(3):1189–1196. doi:10.1016/j.juro.2010.05.028

4. Kemter E et al. Type of uromodulin mutation and allelic status influence onset and severity of uromodulin-associated kidney disease in mice. Hum Mol Genet 2013;22(20):4148–4163. doi:10.1093/hmg/ddt265

5. Devuyst O, Olinger E, Rampoldi L. Uromodulin: from physiology to rare and complex kidney disorders. Nat Rev Nephrol 2017;13(9):525–544. doi:10.1038/nrneph.2017.101

6. Khasun M et al. Uromodulin and kidneys. Nephrology (Saint Petersburg) 2020;24(1):22–38. (In Russ.) doi:10.24884/15616274-2020-24-1-22-38

7. Khasun M et al. Uromodulin and ion excretion in patients with glomerulopathies. Nephrology (Saint Petersburg) 2016;20(1). (In Russ.)

8. Al-Shukri SKh, Gorbachev MI, Goloshchapov ET. Significance of Tamm–Horsfall protein study in patients with bilateral recurrent nephrolithiasis. Nephrology (Saint Petersburg) 2013;17(2). (In Russ.)

9. Mo L et al. Tamm-Horsfall protein is a critical renal defense factor protecting against calcium oxalate crystal formation. Kidney Int 2004;66(3):1159–1166. doi:10.1111/j.15231755.2004.00865.x

10. Wolf MTF, Zhang J, Nie M. Uromodulin in mineral metabolism. Curr Opin Nephrol Hypertens 2019;28(5):481–489. doi:10.1097/MNH.0000000000000535

11. Negri AL, Spivacow FR. Kidney stone matrix proteins: role in stone formation. World J Nephrol 2023;12(2):21–28. doi:10.5527/wjn.v12.i2.21

12. Comparative anatomy and histology. ScienceDirect. Available at: https://www.sciencedirect.com/book/editedvolume/9780123813619/comparative-anatomy-and-histology (accessed 19 Feb 2026)

13. Seok J et al. Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci U S A 2013;110(9):3507–3512. doi:10.1073/pnas.1222878110

14. Khan SR, Glenton PA. Of mice and men: experimental induction of calcium oxalate nephrolithiasis in mice. J Urol 2010;184(3):1189–1196. doi:10.1016/j.juro.2010.05.028

15. Qi Z et al. Serial determination of glomerular filtration rate in conscious mice using FITC-inulin clearance. Am J Physiol Renal Physiol 2004;286(3):F590–F596. doi:10.1152/ajprenal.00324.2003


Review

For citations:


Verlov N.A., Burdakov V.S., Antysheva T.A., Ivanova L.A., Mukhametdinova D.V., Landa S.B., Dyussupova K., Emanuel V.L. Uromodulin as a kidney protective factor in acute oxalate urolithiasis: a dose-dependent mouse model. Nephrology (Saint-Petersburg). 2026;30(2):96-110. (In Russ.) https://doi.org/10.36485/1561-6274-2026-30-2-96-110. EDN: JQBRTS

Views: 36

JATS XML

ISSN 1561-6274 (Print)
ISSN 2541-9439 (Online)